Affimed KOL Event Dec 7
New York, December 7, 2018
Affimed cordially invites you to join management and key opinion leaders for a breakfast in New York City.
Friday, December 7
8:00 am Registration and Breakfast
8:30 am - 11 am Presentations and Q&A
Affimed N.V. [AFMD] US$266 MM MCap
Discovers and develops highly targeted cancer immunotherapies engineered from Affimed’s proprietary, modular ROCK™ (Redirected Optimized Cell Killing) platform that enables the generation of... [more information]